Related Experiment Videos
Management of combined severe carotid and coronary artery disease
Marco Roffi1, Flavio Ribichini, Fausto Castriota
1Interventional Cardiology Unit, Division of Cardiology, University Hospital, Geneva, Switzerland. marco.roffi@hcuge.ch
Insights
Patients with severe carotid and coronary artery disease face high risks. Carotid revascularization decisions should balance stroke prevention and cardiac events, with lifestyle changes crucial for long-term outcomes.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Vascular Surgery
Background:
- Patients with severe carotid and coronary artery disease, particularly those needing coronary artery bypass grafting (CABG), are at elevated risk for cardiac events and stroke.
- Carotid revascularization is a consideration for specific patient groups with carotid disease.
Purpose of the Study:
- To evaluate the considerations for carotid revascularization in patients with concomitant severe carotid and coronary artery disease.
- To compare the risks and benefits of different carotid revascularization strategies, including carotid artery stenting (CAS) versus endarterectomy (CEA), in high-risk patients.
Main Methods:
- Review of clinical guidelines and evidence regarding carotid revascularization in patients with coronary artery disease.
- Analysis of outcomes data comparing carotid artery stenting and carotid endarterectomy, focusing on periprocedural myocardial infarction and stroke.
- Consideration of patient selection criteria for carotid revascularization based on symptom status and stenosis laterality.
Main Results:
- Carotid revascularization is recommended for symptomatic carotid disease and bilateral severe asymptomatic carotid stenosis.
- For unilateral asymptomatic carotid stenosis, the decision favors long-term stroke prevention over perioperative risk reduction.
- Carotid artery stenting shows a lower incidence of periprocedural myocardial infarction compared to endarterectomy, a finding significant for patients undergoing CABG.
Conclusions:
- The choice of carotid revascularization strategy should be individualized, considering the balance of stroke prevention and cardiac risks.
- Carotid artery stenting may offer advantages in reducing periprocedural myocardial infarction for patients with advanced coronary artery disease.
- Comprehensive disease management, including lifestyle modification and pharmacologic prevention, is paramount for improving long-term quality and duration of life, potentially outweighing revascularization benefits alone.
Abstract:
Patients with severe carotid and coronary disease-especially if they require coronary artery bypass grafting (CABG)-are at high risk of cardiac events and stroke. Carotid revascularization should be considered for patients with symptomatic carotid disease and bilateral severe asymptomatic carotid stenosis. In patients with unilateral asymptomatic carotid stenosis, decision to proceed to revascularization should be based more on a perspective of long-term stroke prevention than of perioperative stroke reduction. Compared with endarterectomy, carotid artery stenting is associated with a lower incidence of periprocedural myocardial infarction, an event linked to long-term mortality. This observation may be particularly relevant for patients with advanced coronary artery disease such as those undergoing CABG. Irrespective of the carotid revascularization strategy, a broad disease management approach based on lifestyle modification and pharmacologic cardiovascular prevention is more likely to affect both the quality and duration of life than revascularization itself.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis III: Management
Acute Coronary Syndrome IV: Interprofessional Care
Angina IV: Management
Cardiomyopathy V: Interprofessional Care
Atherosclerosis IV: Nursing Management